1.5.3. Using in-silico medicine for improving disease management and prediction

2013/743/EU: Council Decision of 3 December 2013 establishing the specific programme implementing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing Decisions 2006/971/EC, 2006/972/EC, 2006/973/EC, 2006/974/EC and 2006/975/EC Text with EEA relevance · European Union

Computer simulation-based medical systems using patient-specific data and building on systems medicine approaches and physiological modelling can be used to predict susceptibility to disease, disease evolution and the likely success of medical treatments. Model-based simulation can be used to support clinical trials, predictability of treatment response, and the personalisation and optimisation of treatment.

← anx_I__cpt_1__cpt_6__cpt_1__cpt_5__cpt_2__text_1 · All articles · anx_I__cpt_1__cpt_6__cpt_1__cpt_5__cpt_3__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-04 · Text as adopted (Official Journal); later amendments are not incorporated in this text.